000 03982nam a22004695i 4500
001 978-1-4614-3194-7
003 DE-He213
005 20140220083246.0
007 cr nn 008mamaa
008 120519s2012 xxu| s |||| 0|eng d
020 _a9781461431947
_9978-1-4614-3194-7
024 7 _a10.1007/978-1-4614-3194-7
_2doi
050 4 _aRC927-927.5
072 7 _aMJM
_2bicssc
072 7 _aMED083000
_2bisacsh
082 0 4 _a616.723
_223
100 1 _aErkan, Doruk.
_eeditor.
245 1 0 _aAntiphospholipid Syndrome
_h[electronic resource] :
_bInsights and Highlights from the 13th International Congress on Antiphospholipid Antibodies /
_cedited by Doruk Erkan, Silvia S. Pierangeli.
264 1 _aBoston, MA :
_bSpringer US :
_bImprint: Springer,
_c2012.
300 _aXVII, 312 p. 28 illus., 20 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aOverview of the Last 25 years and 13 International Congresses on Antiphospholipid Antibodies -- What is the Origin of Antiphospholipid Antibodies? -- What is the Genetics of Antiphospholipid Antibodies/Syndrome? -- What is the Mechanism(s) of Antiphospholipid Antibody-mediated Thrombosis? -- What is the Mechanism(s) of Antiphospholipid Antibody-mediated Pregnancy Morbidity? -- What are the Target Cells and Receptors Recognized by Antiphospholipid Antibodies? -- Task Force Report on “Criteria” Antiphospholipid Antibody Tests -- Task Force Report on “Non-Criteria” Antiphospholipid Antibody Tests -- Task Force Report on Obstetric Antiphospholipid Syndrome -- Task Force Report on Brain Involvement in Antiphospholipid Syndrome -- Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome -- Task Force Report on Catastrophic Antiphospholipid Syndrome -- Task Force Report on Non-criteria aPL Manifestations: Thrombocytopenia -- Task Force Report on Non-criteria Manifestations: Nephropathy -- Task Force Report on Non-criteria Manifestations: Cardiac Valve Disease -- Task Force Report on Non-criteria Manifestations: Skin -- Task Force Report on Antiphospholipid Syndrome Clinical Research -- What are the Potential Future Treatments in Antiphospholipid Syndrome? -- Remembrance of Predictions of Past -- What Should Patients Know about Antiphospholipid Antibodies and Antiphospholipid Syndrome?.
520 _aThe International Congress on Antiphospholipid Antibodies is held every three years to discuss the recent advances and future directions in Antiphospholipid Syndrome (APS). This volume collects the scientific highlights  and new findings about APS that were generated from the most recent 13th Congress, held in Galveston, Texas in 2010.  Chapters were written by an internationally-distinguished group of scientists from the point-of-view of multiple specialty areas. Each chapter was written in a uniform and systematic basis to present the latest evidence-based research, including the basic science of APS, task force reports from the Congress on controversial aspects of APS,  and future directions of APS research. This book will appeal to all clinicians involved in the treatment and management of APS patients, to residents in a variety of medical subspecialties, and to research scientists interested in a better understanding of this complex and evolving disease.
650 0 _aMedicine.
650 0 _aAllergy.
650 0 _aInternal medicine.
650 0 _aRheumatology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aRheumatology.
650 2 4 _aInternal Medicine.
650 2 4 _aAllergology.
700 1 _aPierangeli, Silvia S.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461431930
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-3194-7
912 _aZDB-2-SME
999 _c101318
_d101318